LexaGene Initiates Program to Identify UK and South African COVID Sequences
January 13, 2021 08:44 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene to Present at Upcoming SNN Network and H.C. Wainwright Bioconnect 2021 Virtual Events
January 06, 2021 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Starts FDA EUA Study for Point-of-Care COVID-19 Testing
December 30, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 30, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene to Place MiQLab Systems at Two Leading Specialty and Emergency Veterinary Care Hospitals
December 17, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Receives Purchase Order for MiQLab from Ethos Discovery
December 15, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene to Participate at the 13th Annual LD Micro Main Event Conference
December 09, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 09, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Places MiQLab System at the University of Pennsylvania’s School of Veterinary Medicine
November 18, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Receives Purchase Order from a Multinational Biotechnology Company
November 16, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Announces Results of Annual General Shareholder’s Meeting
November 13, 2020 17:00 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene to Present at Two Upcoming Investor Conferences
November 10, 2020 07:58 ET
|
LexaGene Holdings Inc
BEVERLY, Mass, Nov. 10, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...